4.6 Review

Impact of microbiota-immunity axis in pancreatic cancer management

Related references

Note: Only part of the references are listed.
Review Critical Care Medicine

The role of the microbiota in the management of intensive care patients

Piotr Szychowiak et al.

Summary: The composition of the gut microbiota is dynamic and can be influenced by various factors in ICU patients, leading to decreased richness and diversity and dominance of potential pathogens. These alterations are associated with increased risk of infection complications or death. However, correcting microbiota disturbances through interventions like fecal microbiota transplantation or antibiotic inactivators is possible. Therefore, controlling microbiota dysbiosis may be a key factor in managing critically ill patients.

ANNALS OF INTENSIVE CARE (2022)

Article Gastroenterology & Hepatology

The association between bacterobilia and the risk of postoperative complications following pancreaticoduodenectomy

Marina L. Parapini et al.

Summary: Pre-operative biliary bacterial colonisation is associated with infectious complications after pancreaticoduodenectomy. Patients with positive bile cultures have higher rates of major complications and surgical-site infections. Patients with sterile bile cultures have lower risk of complications.
Review Microbiology

The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine

Kelly M. Herremans et al.

Summary: Pancreatic cancer patients have oral microbial shifts that may indicate their risk years before diagnosis, and pathogenic bacteria have been found in pancreatic tumors. Understanding the interaction between the oral microbiome and pancreatic cancer could lead to improved diagnostic and therapeutic approaches, reducing healthcare disparities.

MICROBIOME (2022)

Review Cell Biology

Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications

Suneetha Amara et al.

Summary: Pancreatic cancer is the fourth leading cause of cancer-related death, with limited diagnostic and therapeutic options. Recent research has shown that the host microbiome plays an important role in pancreatic cancer progression, and gut microbiome transplant is believed to improve immunotherapeutic outcomes.

CELLS (2022)

Article Engineering, Biomedical

Polyanhydride nanoparticles stabilize pancreatic cancer antigenMUC4β

Luman Liu et al.

Summary: The study utilized amphiphilic polyanhydride copolymers to synthesize nanoparticles for delivering MUC4 beta protein, which showed stable release and generated specific antibody responses in mice. These results suggest that polyanhydride nanoparticles are promising vaccine carriers for PC immunotherapy.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2021)

Article Surgery

Effect of bacterial contamination in bile on pancreatic cancer cell survival

Hannah R. Shrader et al.

Summary: The study found that alteration of bile microbiome from biliary stenting has a direct impact on pancreatic cancer cell survival, with some contaminated bile even weakening the anti-tumor effect. In addition, conjugated bile acids were more potent than unconjugated ones in reducing pancreatic cancer cell survival.

SURGERY (2021)

Article Engineering, Biomedical

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

Wenxi Zhou et al.

Summary: The study demonstrates a dual delivery biosystem based on exosomes for enhancing PDAC immunotherapy and reversing tumor immunosuppression. By disrupting the galectin-9/dectin 1 axis, the system can improve drug accumulation in the tumor site and elicit anti-tumor immune response.

BIOMATERIALS (2021)

Article Immunology

Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer

Elena Niccolai et al.

Summary: The study revealed higher levels of specific cytokines and bacteria genera in CRC tumor tissues compared to healthy mucosa, with a significant difference between the two groups. Additionally, the presence of certain bacterial genera was found to be positively or negatively correlated with the expression of IL-9 in the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease

Edda Russo et al.

Summary: This study identified differences in cytokine distribution and microbiota composition within Crohn's disease and adjacent healthy ileal tissue layers, as well as between patients undergoing first surgery and surgical relapse. These results provide insight into the gut microbiota-immune axis in Crohn's disease patients and may lead to the discovery of new biomarkers.

JOURNAL OF CROHNS & COLITIS (2021)

Review Chemistry, Multidisciplinary

Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy

Runqi Zhu et al.

Summary: The gut microbiota has significant interactions with the host and can impact cancer progression and treatment outcomes. Modern drug delivery systems are promising tools for modulating gut microbiota to enhance cancer prevention and treatment. This review discusses the essential roles of gut microbiota in carcinogenesis and highlights advances in drug delivery systems aimed at improving cancer therapy by modulating or engineering gut microbiota.

ADVANCED SCIENCE (2021)

Review Medicine, General & Internal

Microbiome-Friend or Foe of Pancreatic Cancer?

Jaroslaw Daniluk et al.

Summary: Pancreatic ductal adenocarcinoma is a deadly neoplasm with poor prognosis, and the human microbiome may play a role in its pathogenesis. This review summarizes the current understanding of how the microbiome influences pancreatic cancer development and progression, discusses its potential as a marker for diagnosis, progression, and survival, and explores the possibility of modifying the microbiome to improve treatment outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Different Biliary Microbial Flora Influence Type of Complications after Pancreaticoduodenectomy: A Single Center Retrospective Analysis

Alessandro Coppola et al.

Summary: The study found a high prevalence of positive biliary cultures intraoperatively, with different bacterial species being associated with postoperative complications. Specifically, Escherichia coli was significantly associated with delayed gastric emptying (DGE) as a unique complication after PD.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biology

Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis

Jae Ri Kim et al.

Summary: Novel microbiome markers were identified by analyzing compositional differences between pancreatic cancer patients and healthy controls, leading to the construction of a high-accuracy prediction model for early diagnosis of pancreatic cancer.

BIOLOGY-BASEL (2021)

Review Biochemistry & Molecular Biology

The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?

Giovanni Brandi et al.

Summary: Recent evidence suggests that microorganisms play a significant role in modulating responses to anticancer treatments and reshaping the tumor-immune microenvironment. Gut microbiota and intra-tumoral bacteria are recognized as crucial components in cancer development and treatment responses. These elements are likely to become important for early diagnosis and risk stratification in the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway

Hiroaki Konishi et al.

Summary: Probiotics exert anti-tumor effects on pancreatic cancer cells by producing heptelidic acid, which acts through the p38 MAPK signaling pathway.

SCIENTIFIC REPORTS (2021)

Review Oncology

The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer

Rozana Abdul Rahman et al.

Summary: Pancreatic cancer is a difficult-to-treat and lethal cancer, with potential interactions with the microbiome affecting patient outcomes and survival. Dysbiosis of the microbiome can lead to diseases, including cancer. Despite advances in cancer treatment, therapy for pancreatic cancer remains challenging.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions

Si-Yuan Lu et al.

Summary: This review discusses the influences of microorganisms on pancreatic cancer chemotherapy, highlighting the significant role of microorganisms in the occurrence and progression of pancreatic cancer, as well as their importance in modulating chemotherapy effects and predicting prognosis as biomarkers. Further studies are necessary to understand the mechanism underlying the interaction between microorganisms and pancreatic cancer.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Surgery

Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer

M. Weniger et al.

Summary: Microbiota may promote the progression of PDAC, with Klebsiella pneumoniae potentially influencing survival in PDAC. The study found that an increasing number of pathogen species in intraoperative bile cultures was associated with decreased progression-free survival, and that quinolone treatment improved overall survival, especially in patients positive for K. pneumoniae.

BRITISH JOURNAL OF SURGERY (2021)

Article Oncology

Antibody Responses to Helicobacter pylori and Risk of Developing Colorectal Cancer in a European Cohort

Julia Butt et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Review Immunology

The Oral Microbiome and Cancer

Muhammad Irfan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Gastroenterology & Hepatology

The Gut Microbiome in Pancreatic Disease

Venkata S. Akshintala et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Biochemistry & Molecular Biology

The microbiota and microbiome in pancreatic cancer: more influential than expected

Miao-Yan Wei et al.

MOLECULAR CANCER (2019)

Review Medicine, General & Internal

Porphyromonas gingivalis and digestive system cancers

Ying Zhou et al.

WORLD JOURNAL OF CLINICAL CASES (2019)

Review Oncology

Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy

Davide Ciardiello et al.

CANCER TREATMENT REVIEWS (2019)

Article Biochemistry & Molecular Biology

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

Erick Riquelme et al.

Article Multidisciplinary Sciences

The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL

Berk Aykut et al.

NATURE (2019)

Article Multidisciplinary Sciences

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

F. Zhang et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Role of the microbiome in occurrence, development and treatment of pancreatic cancer

Yicheng Wang et al.

MOLECULAR CANCER (2019)

Article Gastroenterology & Hepatology

Influence of bile contamination for patients who undergo pancreaticoduodenectomy after biliary drainage

Keiichi Okano et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Oncology

Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice

Concetta Panebianco et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)

Article Gastroenterology & Hepatology

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response

Vrishketan Sethi et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

The Microbiome and Pancreatic Cancer An Evidence-based Association?

Livia Archibugi et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Vinod P. Balachandran et al.

NATURE (2017)

Review Microbiology

Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function

Ingar Olsen et al.

JOURNAL OF ORAL MICROBIOLOGY (2017)

Article Gastroenterology & Hepatology

The interaction between smoking, alcohol and the gut microbiome

Gabriele Capurso et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)

Article Medicine, Research & Experimental

Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer

Elena Niccolai et al.

CLINICAL SCIENCE (2016)

Article Microbiology

Culture of previously uncultured members of the human gut microbiota by culturomics

Jean-Christophe Lagier et al.

NATURE MICROBIOLOGY (2016)

Review Oncology

Immune Checkpoint Blockade in Cancer Therapy

Michael A. Postow et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Immunology

TLR9 ligation in pancreatic stellate cells promotes tumorigenesis

Constantinos P. Zambirinis et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Editorial Material Immunology

The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases

Danilo Pagliari et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2015)

Article Gastroenterology & Hepatology

Complex role for the immune system in initiation and progression of pancreatic cancer

Kristin S. Inman et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Oncology

Role of bacterial infections in pancreatic cancer

Dominique S. Michaud

CARCINOGENESIS (2013)

Review Gastroenterology & Hepatology

The Epidemiology of Pancreatitis and Pancreatic Cancer

Dhiraj Yadav et al.

GASTROENTEROLOGY (2013)

Article Oncology

The Pancreas Cancer Microenvironment

Christine Feig et al.

CLINICAL CANCER RESEARCH (2012)

Review Oncology

Cancer-related inflammation: Common themes and therapeutic opportunities

Frances R. Balkwill et al.

SEMINARS IN CANCER BIOLOGY (2012)

Review Oncology

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

Suzanne Ostrand-Rosenberg

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)